IBDEI1BQ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,21401,2)
;;=^5015556
;;^UTILITY(U,$J,358.3,21402,0)
;;=N06.1^^70^917^14
;;^UTILITY(U,$J,358.3,21402,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21402,1,3,0)
;;=3^Isolated Proteinuria w/ Focal/Segmental Glomerular Lesions
;;^UTILITY(U,$J,358.3,21402,1,4,0)
;;=4^N06.1
;;^UTILITY(U,$J,358.3,21402,2)
;;=^5015550
;;^UTILITY(U,$J,358.3,21403,0)
;;=N06.0^^70^917^15
;;^UTILITY(U,$J,358.3,21403,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21403,1,3,0)
;;=3^Isolated Proteinuria w/ Minor Glomerular Abnormality
;;^UTILITY(U,$J,358.3,21403,1,4,0)
;;=4^N06.0
;;^UTILITY(U,$J,358.3,21403,2)
;;=^5015549
;;^UTILITY(U,$J,358.3,21404,0)
;;=N06.8^^70^917^16
;;^UTILITY(U,$J,358.3,21404,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21404,1,3,0)
;;=3^Isolated Proteinuria w/ Morphologic Lesion
;;^UTILITY(U,$J,358.3,21404,1,4,0)
;;=4^N06.8
;;^UTILITY(U,$J,358.3,21404,2)
;;=^5015557
;;^UTILITY(U,$J,358.3,21405,0)
;;=N14.3^^70^917^25
;;^UTILITY(U,$J,358.3,21405,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21405,1,3,0)
;;=3^Nephropathy Induced by Heavy Metals
;;^UTILITY(U,$J,358.3,21405,1,4,0)
;;=4^N14.3
;;^UTILITY(U,$J,358.3,21405,2)
;;=^5015593
;;^UTILITY(U,$J,358.3,21406,0)
;;=N14.1^^70^917^24
;;^UTILITY(U,$J,358.3,21406,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21406,1,3,0)
;;=3^Nephropathy Induced by Drug/Meds/Biol Subst
;;^UTILITY(U,$J,358.3,21406,1,4,0)
;;=4^N14.1
;;^UTILITY(U,$J,358.3,21406,2)
;;=^5015591
;;^UTILITY(U,$J,358.3,21407,0)
;;=N29.^^70^917^17
;;^UTILITY(U,$J,358.3,21407,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21407,1,3,0)
;;=3^Kidney and Ureter Disorders in Diseases Classd Elsewhr
;;^UTILITY(U,$J,358.3,21407,1,4,0)
;;=4^N29.
;;^UTILITY(U,$J,358.3,21407,2)
;;=^5015631
;;^UTILITY(U,$J,358.3,21408,0)
;;=N15.8^^70^917^26
;;^UTILITY(U,$J,358.3,21408,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21408,1,3,0)
;;=3^Renal Tubulo-Interstitial Diseases
;;^UTILITY(U,$J,358.3,21408,1,4,0)
;;=4^N15.8
;;^UTILITY(U,$J,358.3,21408,2)
;;=^5015595
;;^UTILITY(U,$J,358.3,21409,0)
;;=N14.4^^70^917^27
;;^UTILITY(U,$J,358.3,21409,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21409,1,3,0)
;;=3^Toxic Nephropathy NEC
;;^UTILITY(U,$J,358.3,21409,1,4,0)
;;=4^N14.4
;;^UTILITY(U,$J,358.3,21409,2)
;;=^5015594
;;^UTILITY(U,$J,358.3,21410,0)
;;=N05.6^^70^917^19
;;^UTILITY(U,$J,358.3,21410,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21410,1,3,0)
;;=3^Nephritic Syndrome w/ Dense Deposit Disease,Unspec
;;^UTILITY(U,$J,358.3,21410,1,4,0)
;;=4^N05.6
;;^UTILITY(U,$J,358.3,21410,2)
;;=^5015547
;;^UTILITY(U,$J,358.3,21411,0)
;;=N05.7^^70^917^20
;;^UTILITY(U,$J,358.3,21411,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21411,1,3,0)
;;=3^Nephritic Syndrome w/ Diffuse Crescentic Glomerulonephritis,Unspec
;;^UTILITY(U,$J,358.3,21411,1,4,0)
;;=4^N05.7
;;^UTILITY(U,$J,358.3,21411,2)
;;=^5015548
;;^UTILITY(U,$J,358.3,21412,0)
;;=N05.1^^70^917^21
;;^UTILITY(U,$J,358.3,21412,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21412,1,3,0)
;;=3^Nephritic Syndrome w/ Focal/Segmental Glomerular Lesions,Unspec
;;^UTILITY(U,$J,358.3,21412,1,4,0)
;;=4^N05.1
;;^UTILITY(U,$J,358.3,21412,2)
;;=^5015542
;;^UTILITY(U,$J,358.3,21413,0)
;;=N05.0^^70^917^22
;;^UTILITY(U,$J,358.3,21413,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21413,1,3,0)
;;=3^Nephritic Syndrome w/ Minor Glomerular Abnormality,Unspec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1BQ 3791 printed Nov 22, 2024@17:15:47 Page 2
IBDEI1BQ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,21401,2)
+2 ;;=^5015556
+3 ;;^UTILITY(U,$J,358.3,21402,0)
+4 ;;=N06.1^^70^917^14
+5 ;;^UTILITY(U,$J,358.3,21402,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,21402,1,3,0)
+8 ;;=3^Isolated Proteinuria w/ Focal/Segmental Glomerular Lesions
+9 ;;^UTILITY(U,$J,358.3,21402,1,4,0)
+10 ;;=4^N06.1
+11 ;;^UTILITY(U,$J,358.3,21402,2)
+12 ;;=^5015550
+13 ;;^UTILITY(U,$J,358.3,21403,0)
+14 ;;=N06.0^^70^917^15
+15 ;;^UTILITY(U,$J,358.3,21403,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,21403,1,3,0)
+18 ;;=3^Isolated Proteinuria w/ Minor Glomerular Abnormality
+19 ;;^UTILITY(U,$J,358.3,21403,1,4,0)
+20 ;;=4^N06.0
+21 ;;^UTILITY(U,$J,358.3,21403,2)
+22 ;;=^5015549
+23 ;;^UTILITY(U,$J,358.3,21404,0)
+24 ;;=N06.8^^70^917^16
+25 ;;^UTILITY(U,$J,358.3,21404,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,21404,1,3,0)
+28 ;;=3^Isolated Proteinuria w/ Morphologic Lesion
+29 ;;^UTILITY(U,$J,358.3,21404,1,4,0)
+30 ;;=4^N06.8
+31 ;;^UTILITY(U,$J,358.3,21404,2)
+32 ;;=^5015557
+33 ;;^UTILITY(U,$J,358.3,21405,0)
+34 ;;=N14.3^^70^917^25
+35 ;;^UTILITY(U,$J,358.3,21405,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,21405,1,3,0)
+38 ;;=3^Nephropathy Induced by Heavy Metals
+39 ;;^UTILITY(U,$J,358.3,21405,1,4,0)
+40 ;;=4^N14.3
+41 ;;^UTILITY(U,$J,358.3,21405,2)
+42 ;;=^5015593
+43 ;;^UTILITY(U,$J,358.3,21406,0)
+44 ;;=N14.1^^70^917^24
+45 ;;^UTILITY(U,$J,358.3,21406,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,21406,1,3,0)
+48 ;;=3^Nephropathy Induced by Drug/Meds/Biol Subst
+49 ;;^UTILITY(U,$J,358.3,21406,1,4,0)
+50 ;;=4^N14.1
+51 ;;^UTILITY(U,$J,358.3,21406,2)
+52 ;;=^5015591
+53 ;;^UTILITY(U,$J,358.3,21407,0)
+54 ;;=N29.^^70^917^17
+55 ;;^UTILITY(U,$J,358.3,21407,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,21407,1,3,0)
+58 ;;=3^Kidney and Ureter Disorders in Diseases Classd Elsewhr
+59 ;;^UTILITY(U,$J,358.3,21407,1,4,0)
+60 ;;=4^N29.
+61 ;;^UTILITY(U,$J,358.3,21407,2)
+62 ;;=^5015631
+63 ;;^UTILITY(U,$J,358.3,21408,0)
+64 ;;=N15.8^^70^917^26
+65 ;;^UTILITY(U,$J,358.3,21408,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,21408,1,3,0)
+68 ;;=3^Renal Tubulo-Interstitial Diseases
+69 ;;^UTILITY(U,$J,358.3,21408,1,4,0)
+70 ;;=4^N15.8
+71 ;;^UTILITY(U,$J,358.3,21408,2)
+72 ;;=^5015595
+73 ;;^UTILITY(U,$J,358.3,21409,0)
+74 ;;=N14.4^^70^917^27
+75 ;;^UTILITY(U,$J,358.3,21409,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,21409,1,3,0)
+78 ;;=3^Toxic Nephropathy NEC
+79 ;;^UTILITY(U,$J,358.3,21409,1,4,0)
+80 ;;=4^N14.4
+81 ;;^UTILITY(U,$J,358.3,21409,2)
+82 ;;=^5015594
+83 ;;^UTILITY(U,$J,358.3,21410,0)
+84 ;;=N05.6^^70^917^19
+85 ;;^UTILITY(U,$J,358.3,21410,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,21410,1,3,0)
+88 ;;=3^Nephritic Syndrome w/ Dense Deposit Disease,Unspec
+89 ;;^UTILITY(U,$J,358.3,21410,1,4,0)
+90 ;;=4^N05.6
+91 ;;^UTILITY(U,$J,358.3,21410,2)
+92 ;;=^5015547
+93 ;;^UTILITY(U,$J,358.3,21411,0)
+94 ;;=N05.7^^70^917^20
+95 ;;^UTILITY(U,$J,358.3,21411,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,21411,1,3,0)
+98 ;;=3^Nephritic Syndrome w/ Diffuse Crescentic Glomerulonephritis,Unspec
+99 ;;^UTILITY(U,$J,358.3,21411,1,4,0)
+100 ;;=4^N05.7
+101 ;;^UTILITY(U,$J,358.3,21411,2)
+102 ;;=^5015548
+103 ;;^UTILITY(U,$J,358.3,21412,0)
+104 ;;=N05.1^^70^917^21
+105 ;;^UTILITY(U,$J,358.3,21412,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,21412,1,3,0)
+108 ;;=3^Nephritic Syndrome w/ Focal/Segmental Glomerular Lesions,Unspec
+109 ;;^UTILITY(U,$J,358.3,21412,1,4,0)
+110 ;;=4^N05.1
+111 ;;^UTILITY(U,$J,358.3,21412,2)
+112 ;;=^5015542
+113 ;;^UTILITY(U,$J,358.3,21413,0)
+114 ;;=N05.0^^70^917^22
+115 ;;^UTILITY(U,$J,358.3,21413,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,21413,1,3,0)
+118 ;;=3^Nephritic Syndrome w/ Minor Glomerular Abnormality,Unspec
